Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Pellatt

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2017
Infrequently expressed miRNAs in colorectal cancer tissue and tumor molecular phenotypeMartha L Slattery, Frances Y Lee, Andrew J Pellatt, et al.
Plos One|November 27, 2013
SEPP1 influences breast cancer risk among women with greater native american ancestry: the breast cancer health disparities studyAndrew J Pellatt, Roger K Wolff, Esther M John, et al.
Genes, Chromosomes & Cancer|May 1, 2013
Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities studyAndrew J Pellatt, Roger K Wolff, Gabriela Torres-Mejia, et al.
Diabetologia|December 15, 2025
Diabetogenic processes for insulin resistance-linked hyperinsulinaemia are associated with colorectal cancerXuan Zhou, Magdalena Sevilla-Gonzalez, Amanda I Phipps, et al.
BMC Cancer|July 22, 2025
Detection of oncogenic fusions in colorectal cancer using a partner-agnostic next-generation sequencing approachAndrew J Pellatt, Reagan M Barnett, Sante Gnerre, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Causal relationships between risk of venous thromboembolism and 18 cancers: a bidirectional Mendelian randomisation analysisNaomi Cornish, Philip Haycock, Hermann Brenner, et al.
JCO Precision Oncology|July 16, 2025
Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TTAndrew J Pellatt, Alisha Bent, Nicholas Hornstein, et al.
Cancer Research Communications|May 6, 2024
Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal AdenocarcinomaNicholas J Hornstein, Mohammad A Zeineddine, Betul B Gunes, et al.
International Journal of Epidemiology|December 21, 2023
Causal relationships between risk of venous thromboembolism and 18 cancers: a bidirectional Mendelian randomization analysisNaomi Cornish, Philip Haycock, Hermann Brenner, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Pathway Polygenic Risk Scores (pPRS) for the Analysis of Gene-environment InteractionW James Gauderman, Yubo Fu, Bryan Queme, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 27, 2017
Infrequently expressed miRNAs in colorectal cancer tissue and tumor molecular phenotypeMartha L Slattery, Frances Y Lee, Andrew J Pellatt, et al.
Plos One|November 27, 2013
SEPP1 influences breast cancer risk among women with greater native american ancestry: the breast cancer health disparities studyAndrew J Pellatt, Roger K Wolff, Esther M John, et al.
Genes, Chromosomes & Cancer|May 1, 2013
Telomere length, telomere-related genes, and breast cancer risk: the breast cancer health disparities studyAndrew J Pellatt, Roger K Wolff, Gabriela Torres-Mejia, et al.
Diabetologia|December 15, 2025
Diabetogenic processes for insulin resistance-linked hyperinsulinaemia are associated with colorectal cancerXuan Zhou, Magdalena Sevilla-Gonzalez, Amanda I Phipps, et al.
BMC Cancer|July 22, 2025
Detection of oncogenic fusions in colorectal cancer using a partner-agnostic next-generation sequencing approachAndrew J Pellatt, Reagan M Barnett, Sante Gnerre, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Causal relationships between risk of venous thromboembolism and 18 cancers: a bidirectional Mendelian randomisation analysisNaomi Cornish, Philip Haycock, Hermann Brenner, et al.
JCO Precision Oncology|July 16, 2025
Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TTAndrew J Pellatt, Alisha Bent, Nicholas Hornstein, et al.
Cancer Research Communications|May 6, 2024
Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal AdenocarcinomaNicholas J Hornstein, Mohammad A Zeineddine, Betul B Gunes, et al.
International Journal of Epidemiology|December 21, 2023
Causal relationships between risk of venous thromboembolism and 18 cancers: a bidirectional Mendelian randomization analysisNaomi Cornish, Philip Haycock, Hermann Brenner, et al.
Biorxiv : the Preprint Server for Biology|January 7, 2025
Pathway Polygenic Risk Scores (pPRS) for the Analysis of Gene-environment InteractionW James Gauderman, Yubo Fu, Bryan Queme, et al.
Pageof 5